Skip to content
Screener

Net Income at other companies

Gevo logo
GevoGEVO
-$176.94M-8,353%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$46.71M+22.5%
NAG
Niagen BioscienceNAGE
$6.32M+24.8%
Opko Health logo
Opko HealthOPK
-$8.42M+94.3%
LifeVantage Corporation logo
LifeVantage CorporationLFVN
$1.28M-34.7%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$154M+16.8%

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$69.84M-14.2%
Enterprise value$69.61M-8.2%

Profitability

See full
Net margin-2,909.1%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by eXoZymes, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: eXoZymes, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 3:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-023035
Total operating income2026 / Three Months ended March 31, / -2025 / Three Months ended March 31, / -
Other income/(expense):
Interest income/ (expense), net13,71694,307
Other income/(expense)3,011-
Loss before income taxes(2,370,247)(1,856,421)
Income tax expense--
Net loss$(2,370,247)$(1,856,421)
Net loss per common share – basic and diluted$(0.28)$(0.22)
Weighted average of common shares outstanding – basic and diluted8,458,8478,367,810

Item 1. - Condensed Unaudited Consolidated Financial Statements CONDENSED

FAQ

What is eXoZymes, Inc.'s net income?
eXoZymes, Inc. (EXOZ) reported net income of -$2.37M in Q1 2026.
How has eXoZymes, Inc.'s net income changed year-over-year?
eXoZymes, Inc.'s net income decreased by 27.7% year-over-year, from -$1.86M to -$2.37M.
What is the long-term trend for eXoZymes, Inc.'s net income?
Over 2 years (2023 to 2025), eXoZymes, Inc.'s net income has grown at a 112.0% compound annual growth rate (CAGR), from -$2.04M to -$9.16M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about eXoZymes, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude